What are the opening hours?

Monday 8:30am - 5:30pm Tuesday 8:30am - 5:30pm Wednesday 8:30am - 5:30pm Thursday 8:30am - 5:30pm Friday 8:30am - 5:30pm

Healix, LLC

Healix is the leading national provider of infusion management services, with headquarters based in

We customize our services to make sure that each physician, hospital, academic medical institution, or pharmaceutical company is able to meet their changing goals and responsibilities. Working at Healix means that you have the opportunity to impact thousands of patients each day, while sharpening your clinical or business skills. Find out what it’s like to join the leading company in ambulatory care.

12/29/2025

We are proud to recognize our research team for the recent publication of a new article in Frontiers of Immunology entitled, "Real-world retrospective cohort study evaluating the tolerability of immune globulin intravenous 10% (BIVIGAM®)." Join us in congratulating our physician collaborators, ADMA Biologics, Inc., and the entire Healix Research Team on this important study!

Read the full article here: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1687588/full

To learn more about Healix research, please email us at infusiontherapy@healix.net.

12/23/2025

During this most wonderful time of the year, we wish you a joyful and healthy holiday season! May your celebrations be filled with precious moments with friends and family.

Happy Holidays from Healix!

12/14/2025

Happy Hanukkah to all those who celebrate! May your candles burn bright this season and fill your home with light and peace.

12/09/2025

We are thrilled to congratulate the Healix Research Team, our physician collaborators, and Novartis for the publication of an important new article published in Cardiology and Therapy by Springer Nature entitled, "Real-World Adherence and Effectiveness of Inclisiran in Lowering LDL-C: Results from 1 Year of Follow-Up."

Read the full article here: https://link.springer.com/article/10.1007/s40119-025-00438-0

If you'd like to learn more about our outcomes research or new study opportunities, please email us at infusiontherapy@healix.net or visit https://healix.net/services/outcomes-research/.

11/28/2025

This Thanksgiving, we are deeply grateful for our exceptional team and healthcare workers everywhere who offer life-changing infusion care to the patients who count on them. Thank you for the gift of your time and talents for the good of others. And to the patients who trust Healix with your care - you inspire us daily. Wishing you and your loved ones a joyful Thanksgiving!

11/19/2025

Join us in congratulating CorMedix, Melinta Therapeutics, and Lucinda Van Anglen for the recent article featured in Infectious Disease Special Edition (IDSE) highlighting the retrospective cohort study that was presented at 2025 in Vienna alongside our esteemed physician partners. The article is entitled, "Rezzayo Proves Effective in Candidemia, Candidiasis" by Susan Kreimar, and covers our study "Real-World Experience with Rezafungin: A Novel Long-Acting Echinocandin."

Read the full IDSE article here: https://www.idse.net/Fungal-Infection/Article/10-25/Rezzayo-Proves-Effective-in-Candidemia-Candidiasis/78487

For more information about our research or to partner with Healix on a new study, email us at infusiontherapy@healix.net or visit https://healix.net/services/outcomes-research/.

11/18/2025

The energy at IDWeek was unmatched, and we enjoyed connecting with so many professionals in the field.

If we missed you at the event and you are interested in exploring Infusion Management solutions for your practice, our team is ready to assist you. We provide comprehensive support tailored to your specific needs.

To learn more, contact our team at 1-866-654-2451 or connect with us online at https://bit.ly/3VGl0gJ.

11/11/2025

Today and every day, we honor the brave individuals who have served our nation. Your courage and selfless dedication protect our freedoms and inspire us all.

From the entire team at Healix, we extend our deepest gratitude for your service. 💙

11/06/2025

Simplify Infusion Management with Tailored Solutions from Healix.

Request your Complimentary Financial Analysis today and discover how Healix can transform your infusion services. Connect with us at InfusionTherapy@healix.net or online at Healix.net.

10/20/2025

This National Pharmacy Week, we extend our deepest gratitude to the exceptional pharmacists and pharmacy technicians at Healix and across the healthcare community. Your commitment to service and expertise are fundamental to achieving positive patient outcomes.

Your daily contributions directly support our mission of delivering Patient and Physician Peace of Mind. The specialized care you provide has a significant and positive effect on the lives of patients nationwide. On behalf of the entire Healix organization, thank you for your unwavering dedication and professionalism.
Happy Pharmacy Week!

10/14/2025

features the latest and greatest research in infectious diseases, and the Healix Research Team is excited to be presenting 4 new collaborative studies with our esteemed physician partners. If you'll be attending the meeting, we invite you visit our studies and chat with the presenting authors.

Poster P374: Long-term Effectiveness of Long-Acting Cabotegravir and Rilpivirine in an Infectious Disease Office-Based HIV Program. Presented by Dr. Nikhil Bhayani on 10/20/25 from 12:15-1:30PM ET.

Poster P-1020: Real-World Effectiveness and Health-Related Quality of Life Improvements Using F***l Microbiota, Live-jslm for the Prevention of Recurrent Clostridioides difficile Infection. Presented by Dr. Lucinda Van Anglen on 10/21/25 from 12:15-1:30PM ET. This study will also be included in a Rapid Fire Session entitled, Breaking Bad: Cooking Up Solutions For IP and AS, to be held on 10/21/25 from 12:15-12:45PM ET in Poster Hall B4-5 - Arena 3.

Poster P-1958: Efficacy and Safety of Rezafungin, A Long-Acting Echinocandin. Presented by Dr. Rick Hengel and Dr. Lucinda Van Anglen on 10/22/25 from 12:15-1:30PM ET in Poster Hall B4-5.

Oral Presentation: Early Experience with Use of Pemivibart for the Pre-exposure Prophylaxis of Coronavirus Disease 2019. Presented by Dr. Brian Metzger on 10/22/25 from 3:15-4:30PM ET.

If you're interested in learning more about our research studies or partnering with Healix, contact infusiontherapy@healix.net. We hope to visit with you at IDWeek!

10/08/2025

kicks off on October 19 in Chicago, and we are thrilled to be an exhibitor alongside our colleagues supporting "education for the next era of Chest medicine." If you'll be attending, stop by the Healix booth #740 to learn about how our premier infusion management services deliver Patient and Physician Peace of Mind for practices nationwide.

Learn more about our offerings today at www.healix.net or register to attend the conference at https://www.chestnet.org/learning-and-events/events/chest-annual-meeting. We hope to see you at CHEST 2025!

Address

2150 Town Square Place, Suite 395
Sugar Land, TX
77479

Opening Hours

Monday	8:30am - 5:30pm
Tuesday	8:30am - 5:30pm
Wednesday	8:30am - 5:30pm
Thursday	8:30am - 5:30pm
Friday	8:30am - 5:30pm

Telephone

(281) 295-4000

Website

http://www.healix.net/

Alerts

Be the first to know and let us send you an email when Healix, LLC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Healix, LLC:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Practice
Claim ownership or report listing

Featured

Psych Dimensions

Want your practice to be the top-listed Clinic in Sugar Land?